Sabri Markabi, MD, is the senior vice president of Research and Development and Chief Medical Officer of Alcon Laboratories, Inc., a subsidiary of Alcon, Inc., the world’s largest eye care company. He manages and directs Alcon’s global Research and Development efforts and Regulatory Affairs department.
Dr. Markabi was chosen to take over the role of senior vice president research and development and Chief Scientific Officer in March 2008. Dr. Markabi began his career as a staff neurologist on the faculty of the University Hospital in Tours, France. In 1991, he joined CIBA-GEIGY and assumed positions of increasing responsibilities in France, Switzerland and New Jersey. In 2004, Novartis appointed him Vice President, Global Head of Development for the Ophthalmic Business Unit, where he oversaw the Development organization including R&D strategy, experimental medicine, clinical development, and regulatory affairs.
Dr. Markabi received his medical degree in 1982 from the University of Damascus in Syria. He completed his clinical training and obtained the French Certification in neurology, with additional qualifications in neuropsycopharmacology from the University of Pierre et Marie Curie, Paris, France.